Search Results - "Abbruzzeese, James"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Final results of a phase I and pharmacokinetic study of ?-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors

    Final results of a phase I and pharmacokinetic study of ?-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors by Johansen, Mary, Zukowski, Thomas, Hoff, Paulo M., Newman, Robert A., Ni, Dan, Hutto, Toni, Abbruzzeese, James, Berghorn, Elmer, Hausheer, Frederick, Madden, Timothy

    Published in Cancer chemotherapy and pharmacology (01-05-2004)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors

    Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors by JOHANSEN, Mary, ZUKOWSKI, Thomas, HOFF, Paulo M, NEWMAN, Robert A, DAN NI, HUTTO, Toni, ABBRUZZEESE, James, BERGHORN, Elmer, HAUSHEER, Frederick, MADDEN, Timothy

    Published in Cancer chemotherapy and pharmacology (01-05-2004)
    “…To determine the maximum tolerated dose (MTD) of gamma-methylene-10-deazaaminopterin (MDAM), a unique antifolate structurally similar to methotrexate (MTX), in…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: